Related by context. Frequent words. (Click for all words.) 62 axitinib 61 metastatic renal cell carcinoma 61 resistant ovarian cancer 60 liver metastases 60 relapsed multiple myeloma 59 epithelial ovarian cancer 59 NSCLC 59 relapsed refractory 58 refractory multiple myeloma 58 unresectable 58 renal cell carcinoma 58 advanced NSCLC 57 resected 57 HER2 positive breast cancer 57 castration resistant prostate cancer 57 metastatic melanoma 57 medullary thyroid cancer 57 ASA# 57 neoadjuvant chemotherapy 56 brain metastases 56 lupus nephritis 55 recurrent ovarian cancer 55 acute myelogenous leukemia AML 55 gastrointestinal stromal tumors 55 phase IIb 55 metastatic pancreatic cancer 55 RECIST criteria 55 neoadjuvant 55 tumor recurrence 55 Hodgkin Lymphoma 55 distant metastases 54 soft tissue sarcomas 54 follicular non 54 metastatic prostate cancer 54 androgen independent 54 hepatocellular carcinoma HCC 54 free survival PFS 54 Median survival 54 non squamous 54 gastrointestinal cancers 54 hormone refractory prostate cancer 54 sarcoma 54 hepatocellular carcinoma 54 adjuvant therapy 54 Acute Myeloid Leukemia AML 54 myelodysplastic syndromes MDS 54 evaluable patients 54 phase IIa 53 bone metastasis 53 Carcinoma 53 BAY #-# 53 neuroendocrine tumors 53 cell carcinoma 53 HER2 + 53 CTCL 53 randomized Phase 53 metastatic disease 53 sorafenib 53 HGS ETR1 53 palifosfamide 53 HER2 positive 53 Stage IV 53 metastatic cancer 53 darapladib 53 pancreatic cancer 53 relapsing remitting multiple sclerosis 53 cell lung cancer 53 follicular lymphoma 53 gastric cancer 53 colorectal breast 53 GvHD 52 bone metastases 52 myelofibrosis 52 glioblastoma multiforme GBM 52 decitabine 52 adjuvant chemotherapy 52 GVAX 52 randomized Phase III 52 gastric cancers 52 Torisel 52 evaluable 52 Burkitt lymphoma 52 diagnosed multiple myeloma 52 RTOG 52 HRPC 52 valopicitabine 52 HuMax CD# 52 Cotara 52 vandetanib 52 IMGN# 52 Metastatic 52 chemoradiation 52 temsirolimus 52 plus prednisone 52 metastatic colorectal cancer 52 soft tissue sarcoma 52 chronic HCV 52 dose escalation trial 52 Trastuzumab 52 vinorelbine 52 Cell Lung Cancer